Home Newsfeeds Barclays Maintains Equal-Weight on Everbridge, Lowers Price Target to $32

Barclays Maintains Equal-Weight on Everbridge, Lowers Price Target to $32

Barclays analyst Ryan Macwilliams maintains Everbridge (NASDAQ:EVBG) with a Equal-Weight and lowers the price target from $40 to $32.

byBenzinga Newsdesk

July 26, 2022

1 minute read

Barclays analyst Ryan Macwilliams maintains Everbridge (NASDAQ:EVBG) with a Equal-Weight and lowers the price target from $40 to $32.

Meet Entrepreneur, Crypto Expert Carlos Vivas At Benzinga’s Future Of Digital Assets Event

By Murtuza Merchant

October 18, 9:30 AM

Carlos Vivas, director and senior principal engineer at The Depository Trust & Clearing Corporation (DTCC), is recognized for his contributions to the world of technology and finance.

ETH

EyePoint Pharmaceuticals Q3 EPS $(0.49) Beats $(0.70) Estimate, Sales $10.01M Miss $10.64M Estimate

By Benzinga Newsdesk

November 2, 7:06 AM

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.70) by 30 percent. This is a 15.52 percent increase over losses of $(0.58) per share

EYPT